OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
4251$1261.0059

Keiwa Inc

Commodity ChemicalsVerified

Keiwa Inc maintains a conservative capital structure with a debt-to-equity ratio of 0.09, significantly below the median for the Commodity Chemicals industry, and a current ratio of 3.86, indicating strong liquidity. The company's liquidity position is further reinforced by cash and equivalents of ¥7.88 billion, which covers 111% of its total liabilities of ¥7.08 billion. Profitability metrics show a return on equity (ROE) of 9.51% and a return on assets (ROA) of 7.33%, both exceeding the industry median for Commodity Chemicals. The company's operating margin of 15.98% (¥3.27 billion operating income on ¥20.47 billion revenue) is robust, though it lags behind the top quartile of the industry. Keiwa's revenue is split between two segments: Optical Sheets and Functional Products. The Optical Sheets segment is the primary revenue driver, though the company does not disclose exact revenue shares by segment. Geographically, the company is heavily concentrated in Japan, with no material international revenue disclosed in the latest filings. The company's growth trajectory is modest, with analysts forecasting a mean EPS of ¥175.70 for the current fiscal year, compared to the actual ¥122.08 in the last reported period. This suggests a potential 43.8% year-over-year increase in earnings, though revenue growth is not explicitly outlined in the input data. Risk factors for Keiwa are minimal in the short term, with no immediate liquidity or dilution flags detected. The company's low debt load and strong cash position reduce credit risk, and the absence of dilutive events in the past 12 months suggests a stable capital structure. However, the company's reliance on a narrow geographic base and limited segment diversification could pose medium-term risks. Recent events include the publication of the 2023 annual report, which outlines the company's strategic focus on expanding its functional products portfolio and enhancing optical sheet technologies. No material regulatory or litigation events were disclosed in the latest filings.

30-day price · 4251+81.00 (+6.7%)
Low$1180.00High$1321.00Close$1288.00As of21 May, 00:00 UTC
Profile
CompanyKeiwa Inc
Ticker4251.T
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Keiwa Inc provides functional films and solutions through Ultra Precision technologies in sheeting, laminating, and coating, primarily serving the optical sheets and functional products markets.

Classification. Keiwa is classified in the Basic Materials sector under Commodity Chemicals with 92% confidence, based on verified market data.

Keiwa Inc maintains a conservative capital structure with a debt-to-equity ratio of 0.09, significantly below the median for the Commodity Chemicals industry, and a current ratio of 3.86, indicating strong liquidity. The company's liquidity position is further reinforced by cash and equivalents of ¥7.88 billion, which covers 111% of its total liabilities of ¥7.08 billion. Profitability metrics show a return on equity (ROE) of 9.51% and a return on assets (ROA) of 7.33%, both exceeding the industry median for Commodity Chemicals. The company's operating margin of 15.98% (¥3.27 billion operating income on ¥20.47 billion revenue) is robust, though it lags behind the top quartile of the industry. Keiwa's revenue is split between two segments: Optical Sheets and Functional Products. The Optical Sheets segment is the primary revenue driver, though the company does not disclose exact revenue shares by segment. Geographically, the company is heavily concentrated in Japan, with no material international revenue disclosed in the latest filings. The company's growth trajectory is modest, with analysts forecasting a mean EPS of ¥175.70 for the current fiscal year, compared to the actual ¥122.08 in the last reported period. This suggests a potential 43.8% year-over-year increase in earnings, though revenue growth is not explicitly outlined in the input data. Risk factors for Keiwa are minimal in the short term, with no immediate liquidity or dilution flags detected. The company's low debt load and strong cash position reduce credit risk, and the absence of dilutive events in the past 12 months suggests a stable capital structure. However, the company's reliance on a narrow geographic base and limited segment diversification could pose medium-term risks. Recent events include the publication of the 2023 annual report, which outlines the company's strategic focus on expanding its functional products portfolio and enhancing optical sheet technologies. No material regulatory or litigation events were disclosed in the latest filings.
Key takeaways
  • Keiwa Inc maintains a strong liquidity position with a current ratio of 3.86 and cash reserves covering liabilities.
  • The company's ROE of 9.51% and ROA of 7.33% outperform the Commodity Chemicals industry median.
  • Revenue is concentrated in Japan and split between two segments, with no detailed geographic breakdown provided.
  • Analysts project a 43.8% increase in EPS for the current fiscal year, though revenue growth is not specified.
  • The company's low debt and no dilution flags suggest a stable capital structure, though geographic and segment concentration pose medium-term risks.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyJPY
Revenue$20.47B
Gross profit$8.78B
Operating income$3.27B
Net income$2.27B
R&D
SG&A
D&A
SBC
Operating cash flow$3.55B
CapEx-$3.00B
Free cash flow$701.0M
Total assets$30.95B
Total liabilities$7.08B
Total equity$23.86B
Cash & equivalents$7.88B
Long-term debt$2.24B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$20.47B$3.27B$2.27B$701.0M
FY-1$21.13B$3.45B$2.79B$1.83B
FY-2$17.57B$2.44B$1.98B-$115.8M
FY-3$21.10B$5.45B$4.86B$1.56B
FY-4$18.13B$2.84B$2.57B$1.17B
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$30.95B$23.86B$7.88B
FY-1$32.01B$22.96B$9.94B
FY-2$29.27B$20.36B$7.15B
FY-3$29.33B$18.91B$6.29B
FY-4$28.77B$14.15B$9.03B
PeriodOCFCapExFCFSBC
FY0$3.55B-$3.00B$701.0M
FY-1$5.92B-$2.21B$1.83B
FY-2$2.45B-$2.97B-$115.8M
FY-3$6.76B-$4.57B$1.56B
FY-4$2.18B-$2.63B$1.17B
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$5.41B$844.6M$737.7M
FQ-1$5.15B$1.02B$837.5M
FQ-2$4.93B$150.7M-$107.1M
FQ-3$4.98B$1.26B$800.7M
FQ-4$6.27B$1.64B$1.63B
FQ-5$5.21B$106.2M-$415.1M
FQ-6$5.04B$804.6M$744.7M
FQ-7$4.61B$903.2M$832.7M
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0$30.95B$23.86B$7.88B
FQ-1$29.90B$22.80B$8.00B
FQ-2$29.97B$21.84B$8.02B
FQ-3$30.43B$21.96B$8.55B
FQ-4$32.01B$22.96B$9.94B
FQ-5$29.11B$21.20B$8.16B
FQ-6$30.06B$21.81B$7.44B
FQ-7$28.56B$20.84B$7.80B
PeriodOCFCapExFCFSBC
FQ0$3.55B-$3.00B
FQ-1
FQ-2$2.21B-$1.63B
FQ-3
FQ-4$5.92B-$2.21B
FQ-5
FQ-6$2.06B-$1.19B
FQ-7
Valuation
Market price$1261.00
Market cap$23.34B
Enterprise value$17.70B
P/E10.3
Reported non-GAAP P/E
EV/Revenue0.9
EV/Op income5.4
EV/OCF5.0
P/B1.0
P/Tangible book1.0
Tangible book$23.86B
Net cash$5.64B
Current ratio3.9
Debt/Equity0.1
ROA7.3%
ROE9.5%
Cash conversion1.6%
CapEx/Revenue-14.6%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric4251Activity
Op margin16.0%0.4% medp25 -8.0% · p75 16.0%top quartile
Net margin11.1%2.3% medp25 -11.6% · p75 11.8%above median
Gross margin42.9%20.8% medp25 14.9% · p75 24.0%top quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-14.6%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity9.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Observations
IR observations
Mean recommendation2.00 (1=strong buy, 5=strong sell)
Strong-buy count1.00
Buy count0.00
Hold count1.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate175.70 JPY
Last actual EPS122.08 JPY
Mean revenue estimate21,350,000,000 JPY
Last actual revenue20,473,330,000 JPY
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-13 00:41 UTC#8f39dddd
Market quoteclose JPY 1261.00 · shares 0.02B diluted
no public URL
2026-05-13 00:41 UTC#fb145862
Source: analysis-pipeline (hybrid)Generated: 2026-05-13 00:44 UTCJob: b0ccd7f2